Primer

Regulation of medical technology must keep people safe while not stifling innovation

The rapid speed of medtech innovations has made the task of regulating them more difficult than before. PHOTO: ST FILE
New: Gift this subscriber-only story to your friends and family

SINGAPORE – In late 2011, some 30,000 women were advised by the French authorities to remove their potentially defective breast implants after reports surfaced that the implants could rupture or cause cancer.

Investigations showed that the French manufacturer had used cheap industrial silicone, meant for use in items like computer parts, instead of the medical-grade material it had claimed it was using, in an attempt to boost its profits.

Already a subscriber? 

Read the full story and more at $9.90/month

Get exclusive reports and insights with more than 500 subscriber-only articles every month

Unlock these benefits

  • All subscriber-only content on ST app and straitstimes.com

  • Easy access any time via ST app on 1 mobile device

  • E-paper with 2-week archive so you won't miss out on content that matters to you

Join ST's Telegram channel and get the latest breaking news delivered to you.